Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(™) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU 2018-12-17 16:00
1